A-na Hou

Dr. A-na Hou

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YLYibin Lin
Yibin Lin
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
MSMengwu Shi
Mengwu Shi
AHA-na Hou
A-na Hou
SHSheng Han
Sheng Han
The nuclear factor of activated T cells (NFAT) was first identified as a transcriptional regulator of activated T cells. The NFAT family is involved in the development of tumors. Furthermore, recent evidence reveals that NFAT proteins regulate the development of inflammatory and immune responses. New discoveries have also been made about the mechanisms by which NFAT regulates cancer progression through cancer stem cells (CSC). Here, we discuss the role of the NFAT family in the immune system and various cancer types.

7 August 2024 in Oncogene
Verified
Journal Article
Closed access
PDF file
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
ZWZixun Wang
Zixun Wang
YLYibin Lin
Yibin Lin
XCXu Cao
Xu Cao
SHSheng Han
Sheng Han

22 June 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
MSMengwu Shi
Mengwu Shi
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
LLLongjie Li
Longjie Li
JYJuanhan Yu
Juanhan Yu
SHSheng Han
Sheng Han
Objective: To investigate the levels of tumor-infiltrating CD8+ lymphocytes (CD8+ TILs) and the expression of programmed cell death receptor ligand 1 (PD-L1) in the tumor microenvironment (TME) of pediatric and adolescent pituitary adenomas (PAPAs) and analyze the correlation between their levels and the clinical characteristics.Methods: A series of 43 PAPAs cases were enrolled over a period of 5 years. To compare the TME of PAPAs and adult PAs, 43 PAPAs cases were matched with 60 adult PAs cases (30 cases were between 20 and 40 years old, and 30 cases were older than 40 years) for main clinical characteristics. The expression of immune markers in PAPAs was detected by immunohistochemistry, and their correlation with the clinical outcomes was analyzed using statistical methods.Results: In the PAPAs group, CD8+ TILs level was significantly lower (3.4 (5.7) vs. 6.1 (8.5), p = 0.001), and PD-L1 expression (0.040 (0.022) vs. 0.024 (0.024), p < 0.0001) was significantly higher as compared with the older group. The level of CD8+ TILs was negatively correlated with the expression of PD-L1 (r = −0.312, p = 0.042). Moreover, CD8+ TILs and PD-L1 levels were associated with Hardy (CD8, p = 0.014; PD-L1, p = 0.018) and Knosp (CD8, p = 0.02; PD-L1, p = 0.017) classification. CD8+ TILs level was associated with high-risk adenomas (p = 0.015), and it was associated with the recurrence of PAPAs (HR = 0.047, 95% CI 0.003–0.632, p = 0.021).Conclusion: Compared with the TME in adult PAs, the TME in PAPAs was found to express a significantly altered level of CD8+ TILs and PD-L1. In PAPAs, CD8+ TILs and PD-L1 levels were associated with clinical characteristics.

2 September 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
GTGuofeng Tian
Guofeng Tian
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
LKLiang kan
Liang kan
AHA-na Hou
A-na Hou
SHSheng Han
Sheng Han
Glioma represents the most prevalent primary tumors of the central nervous system, originating from glial cells. Cancer stem cells have the ability to extensively proliferate, self-renew, and form colonies, which contribute to tumorigenesis. Studies have found a population of cells within glioblastoma exhibiting characteristics similar to those of cancer cells, termed glioma stem cells (GSCs). GSCs have two distinct phenotypes: mesenchymal subtype (MES) and proneural subtype (PN). Despite the vital role of these subtypes in glioma biology, there is a significant lack of comprehensive reviews focusing on the regulatory mechanisms underlying each phenotype.This review integrates emerging insights into the regulatory mechanisms underlying GSCs plasticity, with dedicated analysis of novel pathways governing PN and MES phenotypes and their dynamic transition. By examining these critical elements, we aim to contribute to the development of novel therapeutic strategies in the ongoing fight against gliomas.

8 October 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
XCXu Cao
Xu Cao
YZYaochuan Zhang
Yaochuan Zhang
YSYifu Song
Yifu Song
YLYibin Lin
Yibin Lin
XHXiaodi Han
Xiaodi Han
SHSheng Han
Sheng Han

18 March 2026 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
YZYaochuan Zhang
Yaochuan Zhang
XCXu Cao
Xu Cao
YSYifu Song
Yifu Song
XHXiaodi Han
Xiaodi Han
GTGuofeng Tian
Guofeng Tian
SHSheng Han
Sheng Han
Neuroinflammation and angiogenesis are central to post-stroke repair. However, the cellular and molecular mechanisms regulating these events remain incompl